Senhwa Wins TFDA Clearance for CX-5461 Immunotherapy Trial
Taiwan, August 6, 2026 Senhwa Biosciences, Inc. has received Taiwan Food and Drug Administration (TFDA) clearance for a multicenter...
AAV9 Gene Therapy
Advertisement
Galibra Neuroscience Wins FDA Designations for SSADH Therapy
Boston, Massachusetts, August 5, 2026 Galibra Neuroscience has received both Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation...
Phoenix Nest Secures $2.98M to Advance JLK-247 Gene Therapy
Brooklyn, New York, August 5, 2026 Phoenix Nest Inc. has been awarded a $2,984,658 Small Business Innovation Research (SBIR)...
Neurogene Highlights Rett Gene Therapy Progress at ASGCT
NEW YORK, May 12, 2026 Neurogene presented new data at the 2026 American Society of Gene and Cell Therapy...
Advertisement
